| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Growth Biology Laboratory, United States Department of Agriculture, Agricultural Research Service (T.H.E., S.K., C.L.), Beltsville, Maryland 20705; Cancer Center, University of California San Diego (C.M., B.N.), La Jolla, California 92093; and Department of Anatomy, Physiology & Pharmacology (J.L.S.), Auburn University, Auburn, Alabama 36849
Address all correspondence and requests for reprints to: Dr. Ted H. Elsasser, United States Department of Agriculture, Agricultural Research Service, Growth Biology Laboratory, B-200, Room 201, Beltsville Agricultural Research Center-East, Beltsville, Maryland 20705. E-mail: elsasser{at}anri.barc.usda.gov.
The present study defined the effects of GH administration on components of the nitric oxide (NO)-generating cascade to account for observed increases in NO production and protein nitration after an immune challenge. Calves were assigned to groups with or without GH treatment (100 µg GH/kg body weight or placebo im, daily for 12 d) and with or without low-level endotoxin [lipopolysaccharide (LPS), 2.5 µg/kg, or placebo, iv]. Plasma was obtained for estimation of NO changes as [NO2 + NO3] (NOx). Transcutaneous liver biopsies were collected for measurement of protein tyrosine nitration, cationic amino acid transporter (CAT)-2 mRNA transporter, and constitutive NO synthase (cNOS), inducible NOS (iNOS), and arginase activity. Liver protein nitration increased more than 10-fold 24 h after LPS and an additional 2-fold in animals treated with GH before LPS. GH increased plasma NOx after LPS to levels 27% greater than those measured in non-GH-treated calves. LPS increased CAT-2 mRNA after LPS; GH was associated with a 24% reduction in CAT-2 mRNA content at the peak time response. cNOS activity was 3-fold greater than iNOS after LPS. NOS activities were increased 140% (cNOS) at 3 h and 169% (iNOS) at 6 h, respectively, after LPS; GH treatment increased cNOS activity and the phosphorylation of endothelial NOS after LPS more than 2-fold over that measured in non-GH-treated calves. The data suggest that an increased production of nitrated protein develops in the liver during low-level, proinflammatory stress, and nitration is increased by GH administration through a direct effect on the competing activities of NOS and arginase, modulatable critical control points in the proinflammatory cascade.
This article has been cited by other articles:
![]() |
J. L. Sartin, D. L. Marks, C. D. McMahon, J. A. Daniel, P. Levasseur, C. G. Wagner, B. K. Whitlock, and B. P. Steele Central role of the melanocortin-4 receptors in appetite regulation after endotoxin J Anim Sci, October 1, 2008; 86(10): 2557 - 2567. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Grasemann, F. Ratjen, D. Schnabel, E. Reutershahn, U. Vester, and H. Grasemann Effect of growth hormone therapy on nitric oxide formation in cystic fibrosis patients Eur. Respir. J., April 1, 2008; 31(4): 815 - 821. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. H. Elsasser, T. J. Caperna, C-J. Li, S. Kahl, and J. L. Sartin Critical control points in the impact of the proinflammatory immune response on growth and metabolism J Anim Sci, April 1, 2008; 86(14_suppl): E105 - E125. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. H. Elsasser, C.-J. Li, T. J. Caperna, S. Kahl, and W. F. Schmidt Growth Hormone (GH)-Associated Nitration of Janus Kinase-2 at the 1007Y-1008Y Epitope Impedes Phosphorylation at This Site: Mechanism for and Impact of a GH, AKT, and Nitric Oxide Synthase Axis on GH Signal Transduction Endocrinology, August 1, 2007; 148(8): 3792 - 3802. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. H. Elsasser, S. Kahl, C.-J. Li, J. L. Sartin, W. M. Garrett, and J. Rodrigo Caveolae Nitration of Janus Kinase-2 at the 1007Y-1008Y Site: Coordinating Inflammatory Response and Metabolic Hormone Readjustment within the Somatotropic Axis Endocrinology, August 1, 2007; 148(8): 3803 - 3813. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Aisemberg, C. Vercelli, S. Billi, M. L. Ribeiro, D. Ogando, R. Meiss, S. M. McCann, V. Rettori, and A. M. Franchi Nitric oxide mediates prostaglandins' deleterious effect on lipopolysaccharide-triggered murine fetal resorption PNAS, May 1, 2007; 104(18): 7534 - 7539. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Christen, I. Cattin, I. Knight, P. G. Winyard, J. W. Blum, and T. H. Elsasser Plasma S-Nitrosothiol Status in Neonatal Calves: Ontogenetic Associations with Tissue-Specific S-Nitrosylation and Nitric Oxide Synthase Experimental Biology and Medicine, February 1, 2007; 232(2): 309 - 322. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Daniel, T. H. Elsasser, A. Martinez, B. Steele, B. K. Whitlock, and J. L. Sartin Interleukin-1{beta} and tumor necrosis factor-{alpha} mediation of endotoxin action on growth hormone Am J Physiol Endocrinol Metab, October 1, 2005; 289(4): E650 - E657. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. H. Elsasser, J. W. Blum, and S. Kahl Characterization of calves exhibiting a novel inheritable TNF-{alpha} hyperresponsiveness to endotoxin: associations with increased pathophysiological complications J Appl Physiol, June 1, 2005; 98(6): 2045 - 2055. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |